Andreatta M, Karosiene E, Rasmussen M, Stryhn A, Buus S, Nielsen M
It is commonly discussed as part of wellness-focused programs involving recovery support, healthy aging, sleep quality, body composition goals, exercise recovery, and overall vitality
GLP-1 therapy is contraindicated in patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, uncontrolled diabetes, or severe renal impairment
Plasma recipients include immunocompromised patients, burn victims, and people with clotting disorderspopulations where any unknown medication component could pose risk
Hyperammonemic encephalopathy : May cause obtundation and seizures (with the potential to progress to coma and death)
Product quality concerns : Most BPC-157 available online is sourced from unregulated compounding facilities, increasing the risk of contamination, inconsistent dosing, and impurities